OncoTAb
Sandra Gendler, Ph.D. is on the Scientific Advisory Board of OncoTAb. She is a Professor of Biochemistry and Molecular Biology at the Mayo Clinic and was recognized for distinction in her field by the appointment of the David F. and Margaret T. Grohne Research Professorship in Therapeutics in Cancer Research. She originally cloned the gene for the MUC1 tumor antigen and she is now translating MUC1-specific therapy into the clinic.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
OncoTAb
OncoTAb, Inc., a North Carolina-based biotechnology company, was founded by Mayo Clinic alumna Dr. Pinku Mukherjee, with a mission to improve the quality of cancer care by addressing unmet cancer diagnostic and therapeutic needs.